Stephen Weis, DO

Research output

Research output per year 1988 2000 2001 2002 2003 2005 2006 2007 2008 2009 2010 2011 2015 2022

• 89 Article
• 5 Letter
• 3 Editorial
• 3 Review article
• 4 More
  • 1 Chapter
  • 1 Conference contribution
  • 1 Comment/debate
  • 1 Short survey

Research output per year

Research output per year

Search results

• Contribution of CD8⁺ T cells to gamma interferon production in human tuberculosis

  Shams, H., Wizel, B., Weis, S. E., Samten, B. & Barnes, P. F., 2001, In: Infection and Immunity. 69, 5, p. 3497-3501 5 p.

  Research output: Contribution to journal › Article › peer-review

  • interferon-gamma 100%
  • tuberculosis 99%
  • T-lymphocytes 79%
  • Mycobacterium tuberculosis 78%
  • Interferon-gamma 78%

• Mortality hazard and survival after tuberculosis treatment

  Miller, T. L., Wilson, F. A., Pang, J. W., Beavers, S., Hoger, S., Sharnprapai, S., Pagaoa, M., Katz, D. J. & Weis, S. E., 1 May 2015, In: American journal of public health. 105, 5, p. 930-937 8 p.

  Research output: Contribution to journal › Article › peer-review

  • contagious disease 100%
  • mortality 85%
  • Tuberculosis 84%
  • Survival 56%
  • Mortality 51%

• Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy

  Lacko, A. G., Kudchodkar, B. J., Loney, W. W., Clearfield, M. B. & Weis, S., 1998, In: Clinical Chemistry and Laboratory Medicine. 36, 6, p. 389-392 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Gemfibrozil 100%
  • High-Density Lipoprotein Cholesterol 98%
  • HDL Cholesterol 56%
  • High-Density Lipoprotein 26%
  • HDL Lipoproteins 16%

• Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort

  Clearfield, M. B., Weis, S., Willis, J. M., Vasenius, K. A. & Mcconathy, W. J., 1 Aug 2002, In: Journal of the American Osteopathic Association. 102, 7, p. 377-384 8 p.

  Research output: Contribution to journal › Article › peer-review

  • LDL Cholesterol 100%
  • Coronary Artery Disease 91%
  • Air 88%
  • Serum 50%
  • Lipids 31%

• Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

  Gotto, A. M., Boccuzzi, S. J., Cook, J. R., Alexander, C. M., Roehm, J. B., Meyer, G. S., Clearfield, M., Weis, S. & Whitney, E., 1 Dec 2000, In: American Journal of Cardiology. 86, 11, p. 1176-1181 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Lovastatin 100%
  • Coronary Artery Disease 62%
  • Air 60%
  • Costs and Cost Analysis 46%
  • Hospitalization 41%

• Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

  Burman, W., Benator, D., Vernon, A., Khan, A., Jones, B., Silva, C., Lahart, C., Weis, S., King, B., Mangura, B., Weiner, M. & El-Sadr, W., 1 Feb 2006, In: American Journal of Respiratory and Critical Care Medicine. 173, 3, p. 350-356 7 p.

  Research output: Contribution to journal › Article › peer-review

  • rifamycin SV 100%
  • Rifabutin 67%
  • Tuberculosis 52%
  • HIV 44%
  • CD4 Lymphocyte Count 37%

• Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease

  Reagin, H., Marks, E., Weis, S. & Susa, J., 1 Sep 2018, In: American Journal of Dermatopathology. 40, 9, p. 682-685 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Sickle Cell Anemia 100%
  • Ulcer 55%
  • Sickle Cell Trait 44%
  • African Americans 28%
  • Cicatrix 26%

• Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: A randomised clinical trial

  Benator, D., Bhattacharya, M., Bozeman, L., Burman, W., Catanzaro, A., Chaisson, R., Gordin, F., Horsburgh, C. R., Horton, J., Khan, A., Lahart, C., Metchock, B., Pachucki, C., Stanton, L., Vernon, A., Villarino, M. E., Yong, C. W., Weiner, M., Weis, S., Horsburgh, C. R., & 1 othersBurman, W., 17 Aug 2002, In: Lancet. 360, 9332, p. 528-534 7 p.

  Research output: Contribution to journal › Article › peer-review

  • rifapentine 100%
  • Isoniazid 67%
  • Rifampin 62%
  • Pulmonary Tuberculosis 62%
  • HIV 41%

• Foreign-born status and geographic patterns of tuberculosis genotypes in Tarrant County, Texas

  Oppong, J. R., Denton, C. J., Moonan, P. K. & Weis, S. E., Nov 2007, In: Professional Geographer. 59, 4, p. 478-491 14 p.

  Research output: Contribution to journal › Article › peer-review

  • tuberculosis 100%
  • genotype 81%
  • contagious disease 73%
  • immigrant 45%
  • infectious disease 24%

• Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

  Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S. & Gotto, A. M., 28 Jun 2001, In: New England Journal of Medicine. 344, 26, p. 1959-1965 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Primary Prevention 100%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 94%
  • C-Reactive Protein 85%
  • Lovastatin 77%
  • Numbers Needed To Treat 36%

• Effect of pedal rate on cardiorespiratory responses during continuous exercise

  Hagan, R. D., Weis, S. E. & Raven, P. B., Oct 1992, In: Medicine and Science in Sports and Exercise. 24, 10, p. 1088-1095 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Foot 100%
  • Heart Rate 57%
  • Ventilation 46%
  • Ergometry 35%
  • Lactic Acid 23%

• Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection

  Shams, H., Weis, S. E., Klucar, P., Lalvani, A., Moonan, P. K., Pogoda, J. M., Ewer, K. & Barnes, P. F., 1 Nov 2005, In: American Journal of Respiratory and Critical Care Medicine. 172, 9, p. 1161-1168 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Enzyme-Linked Immunospot Assay 100%
  • Latent Tuberculosis 98%
  • Tuberculin Test 95%
  • Tuberculin 89%
  • Skin Tests 77%

• Using the St. George Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis

  Pasipanodya, J. G., Miller, T. L., Vecino, M., Munguia, G., Bae, S., Drewyer, G. & Weis, S. E., Nov 2007, In: Chest. 132, 5, p. 1591-1598 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Pulmonary Tuberculosis 100%
  • Latent Tuberculosis 55%
  • Health 46%
  • Tuberculosis 26%
  • Quality of Life 20%

• General health status and adherence to antiretroviral therapy

  Cardarelli, R., Weis, S., Adams, E., Radaford, D., Vecino, I., Munguia, G., Johnson, K. L. & Fulda, K. G., May 2008, In: Journal of the International Association of Physicians in AIDS Care. 7, 3, p. 123-129 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Highly Active Antiretroviral Therapy 100%
  • Health Status 77%
  • HIV 46%
  • Hispanic Americans 42%
  • Acquired Immunodeficiency Syndrome 37%

• CREB, ATF, and AP-1 transcription factors regulate IFN-γ secretion by human T cells in response to mycobacterial antigen

  Samten, B., Townsend, J. C., Weis, S. E., Bhoumik, A., Klucar, P., Shams, H. & Barnes, P. F., 1 Aug 2008, In: Journal of Immunology. 181, 3, p. 2056-2064 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Transcription Factor AP-1 100%
  • Antigens 57%
  • T-Lymphocytes 55%
  • Transcription Factors 40%
  • Cyclic AMP Response Element Modulator 32%

• Evaluation of gemfibrozil therapy: Predictive response from lipoprotein subfraction analysis

  Loney, W. W., Kudchodkar, B. J., Weis, S., Clearfield, M. B., Shores, J. & Lacko, A. G., 1997, In: American Journal of Therapeutics. 4, 9-10, p. 301-309 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Gemfibrozil 100%
  • Lipoproteins 64%
  • HDL Cholesterol 60%
  • Triglycerides 31%
  • Lipids 18%

• Design and rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

  Downs, J. R., Beere, P. A., Whitney, E., Clearfield, M., Weis, S., Rochen, J., Stein, E. A., Shapiro, D. R., Langendorfer, A. & Gotto, A. M., 1 Aug 1997, In: American Journal of Cardiology. 80, 3, p. 287-293 7 p.

  Research output: Contribution to journal › Article › peer-review

  • LDL Cholesterol 100%
  • Coronary Artery Disease 91%
  • Air 88%
  • Lovastatin 73%
  • Primary Prevention 57%

• The effects of local review on informed consent documents from a multicenter clinical trials consortium

  Burman, W., Breese, P., Weis, S., Bock, N., Bernardo, J. & Vernon, A., Jun 2003, In: Controlled Clinical Trials. 24, 3, p. 245-255 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Consent Forms 100%
  • Multicenter Studies 64%
  • Clinical Trials 48%
  • Research Ethics Committees 12%
  • Reading 10%

• Causes and costs of hospitalization of tuberculosis patients in the United States

  Taylor, Z., Marks, S. M., Rios Burrows, N. M., Weis, S. E., Stricof, R. L. & Miller, B., 1 Jan 2000, In: International Journal of Tuberculosis and Lung Disease. 4, 10, p. 931-939 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Tuberculosis 100%
  • Hospitalization 89%
  • Costs and Cost Analysis 75%
  • Length of Stay 27%
  • HIV 16%

• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS

  Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W. & Gotto, A. M., 27 May 1998, In: Journal of the American Medical Association. 279, 20, p. 1615-1622 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Lovastatin 100%
  • Primary Prevention 77%
  • LDL Cholesterol 59%
  • Cholesterol 55%
  • Unstable Angina 31%

• Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States

  Miller, T. L., Hilsenrath, P., Lykens, K., Mcnabb, S. J. N., Moonan, P. K. & Weis, S. E., Apr 2006, In: Annals of Epidemiology. 16, 4, p. 305-312 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Health Care Costs 100%
  • Tuberculosis 91%
  • Infections 12%
  • Homeless Persons 8%
  • Latent Tuberculosis 8%

• Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women

  Weis, S. E., Vecino, I., Pogoda, J. M. & Susa, J. S., Dec 2012, In: Diseases of the Colon and Rectum. 55, 12, p. 1236-1243 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Primary Health Care 100%
  • HIV 87%
  • Population 49%
  • Neoplasms 40%
  • Squamous Cell Carcinoma 39%

• Effectiveness of an intervention to overcome influenza vaccine hesitancy in specialty clinic patients

  Webb, N. J., Lindsley, J., Stockbridge, E. L., Workman, A., Reynolds, C. D., Miller, T. L., Charles, J., Carletti, M., Casperson, S. & Weis, S., 29 Jul 2022, In: Medicine (United States). 101, 30, p. E29786

  Research output: Contribution to journal › Article › peer-review

  • Influenza Vaccines 100%
  • Human Influenza 80%
  • Immunization 57%
  • Vaccination 54%
  • Immunosuppressive Agents 32%

• Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial

  The SMART Study Group, 2 Sep 2008, In: Annals of Internal Medicine. 149, 5, p. 289-299 11 p.

  Research output: Contribution to journal › Article › peer-review

  • HIV 100%
  • CD4 Lymphocyte Count 44%
  • Therapeutics 23%
  • RNA 15%
  • Randomized Controlled Trials 4%

• Personal and societal health quality lost to tuberculosis

  Miller, T. L., McNabb, S. J. N., Hilsenrath, P., Pasipanodya, J. & Weis, S. E., 8 Apr 2009, In: PLoS ONE. 4, 4, e5080.

  Research output: Contribution to journal › Article › peer-review

  • tuberculosis 100%
  • quality-adjusted life year 99%
  • Quality-Adjusted Life Years 76%
  • Tuberculosis 72%
  • Health 43%